secwatch.observer — SEC 8-K summary
======================================

Issuer:     Denali Therapeutics Inc. (DNLI)
CIK:        0001714899
Form:       8-K
Filed at:   2024-05-31T23:59:59+00:00
Accession:  0001714899-24-000125
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Denali shareholders elect directors, ratify auditor, approve executive compensation
--------------------------------------------------------------------------------

- Three Class I directors elected: Jay Flatley (108.1M for), Mac Tessier-Lavigne (82.2M for), Nancy Thornberry (108.3M for).
- Ernst & Young ratified as auditor for FY2024 with 118.0M for, 297k against.
- Say-on-pay advisory vote passed with 101.6M for, 8.6M against.
- Meeting had 83.0% of outstanding shares present (118.3M of 142.5M shares).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1714899/000171489924000125/0001714899-24-000125-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1714899/000171489924000125/dnli-20240531.htm
  HTML page:      https://secwatch.observer/filing/0001714899-24-000125

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer